Headlines
•Eli Lilly inks gene therapy deal with Profluent — up to $2.25B in deal value
•JetBlue cuts capacity and hikes fares after higher fuel costs widened quarterly loss — fares rise as costs pressure results
•InsCorp declares quarterly dividend — $0.12 per share
•Pentair Q1 beats estimates and raises FY2026 outlook — EPS guidance lifted to $5.30–$5.40
•National Mining Museum strike ends — workers secure a 10.5% pay rise
•Eccles battery storage system plan secures financing — 245m deal advances the project